-
Product Insights
NewBreath of Health Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Breath of Health Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Breath of Health (BOH) is a distributer of breath testing system. BOH is headquartered in Rechovot, Israel. GlobalData's Medical Devices company profile report, “Breath of Health Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data related to: Top level information about...
-
Product Insights
NewCannabix Technologies Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Cannabix Technologies Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Cannabix Technologies Inc (Cannabix Technologies) is a technology company. It develops marijuana breathalyzer tools for law enforcement and the workplace to detect THC in breath. It provides breath testing technologies in the pursuit of bringing durable, portable hand-held tools to the market to enhance detection of marijuana impaired driving offences on roads. The company develops drug-testing devices that detect...
-
Product Insights
NewMenssana Research Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Menssana Research Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Menssana Research Inc (Menssana) is a medical device development company that develops breath test systems. It offers BreathLink a cloud application that concentrates, collects and analyzes organic compounds in human breath. It also provides Breathscanner a mobile point of care system that uploads the results to lab through the Internet. Menssana’ breath test system is used in clinical studies...
-
Product Insights
NewAvisa Pharma Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Avisa Pharma Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic diseases; and avisar spec, a point-of-care instrument that is used for measuring exhaled carbondioxide....
-
Sector Analysis
Breathing Filters and Bags Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Breathing Filters and Bags Market Report Overview The breathing filters and bags market size was valued at $210.3 million in 2023. The market is anticipated to grow at a CAGR of more than 2% during the forecast period 2023-2033. Breathing filters are single-used disposable HME (Heat Moisture Exchange) devices utilized in airway circuits to filter humidified air or anesthetic gases. On the other hand, breathing bags are foldable bags from which gases can be inhaled or exhaled during artificial ventilation...
-
Product Insights
Likelihood of Approval Analysis for Apnea
Overview How likely is it that the drugs in Apnea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apnea Overview Sleep apnea is a disorder that causes you to stop breathing...
-
Product Insights
NewOwlstone Medical Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Owlstone Medical Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Owlstone Medical Ltd (Owlstone Medical), is a diagnostic company that develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications, Lonestar for disease biomarker detection and ATLAS for volatile organic compounds sampling from clinical sample. Owlstone Medical provides UltraFAIMS for enhanced mass spectrometry for medical research simulated human breath (SiHuB)...
-
Product Insights
Likelihood of Approval Analysis for Pulmonary Fibrosis
Overview How likely is it that the drugs in Pulmonary Fibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pulmonary Fibrosis Overview Pulmonary fibrosis is a lung disease that causes lung...
-
Product Insights
Likelihood of Approval Analysis for Respiratory Distress Syndrome
Overview How likely is it that the drugs in Respiratory Distress Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Distress Syndrome Overview Respiratory distress syndrome (RDS) occurs in babies...
-
Product Insights
Likelihood of Approval Analysis for Obstructive Pulmonary Disease
Overview How likely is it that the drugs in Obstructive Pulmonary Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obstructive Pulmonary Disease Overview Chronic obstructive pulmonary disease (COPD) is a...